Your browser doesn't support javascript.
loading
Coronavirus Disease 2019 (COVID-19): A Haematologist's Perspective.
Acta Haematol ; 144(1): 10-23, 2021.
Article in En | MEDLINE | ID: mdl-32721958
Coronavirus disease 2019 (COVID-19) is affecting millions of patients worldwide. It is caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which belongs to the family Coronaviridae, with 80% genomic similarities to SARS-CoV. Lymphopenia was commonly seen in infected patients and has a correlation to disease severity. Thrombocytopenia, coagulation abnormalities, and disseminated intravascular coagulation were observed in COVID-19 patients, especially those with critical illness and non-survivors. This pandemic has caused disruption in communities and hospital services, as well as straining blood product supply, affecting chemotherapy treatment and haematopoietic stem cell transplantation schedule. In this article, we review the haematological manifestations of the disease and its implication on the management of patients with haematological disorders.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Thrombocytopenia / Hematopoietic Stem Cell Transplantation / Disseminated Intravascular Coagulation / Pandemics / SARS-CoV-2 / Lymphopenia Limits: Humans Language: En Journal: Acta Haematol Year: 2021 Document type: Article Country of publication: Switzerland

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Thrombocytopenia / Hematopoietic Stem Cell Transplantation / Disseminated Intravascular Coagulation / Pandemics / SARS-CoV-2 / Lymphopenia Limits: Humans Language: En Journal: Acta Haematol Year: 2021 Document type: Article Country of publication: Switzerland